Roles of p51/p63 in the organogenesis, differentiation and carcinogenesis of the urothelium
Roles of p51/p63 in the organogenesis, differentiation and carcinogenesis of the urothelium
批准号:
14571489
负责人:
KAWAKAMI Satoru
金额:
$2.18万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
p63在人尿路上皮细胞中的表达采用免疫细胞化学和RT-PCR方法检测了p63蛋白和mRNA在体外培养的人尿路上皮细胞和人尿路上皮癌细胞系中的表达。p63在正常人尿路上皮和尿路上皮癌组织中的表达采用免疫组化和RT-PCR方法检测p63蛋白和p63 mRNA在正常人尿路上皮和膀胱癌组织中的表达,分别在正常人尿路上皮细胞中,p63表达于基底层至中间层的细胞核,仅表达ΔN亚型。这种表达模式在高分化、非高分化的乳腺癌中得以保留。 ...更多信息 - 浸润性膀胱癌,而在低分化浸润性膀胱癌中减少或消失。在浸润性膀胱癌组织中,我们发现Δ Np 63表达降低与β-catenin表达降低显著相关,已知β-catenin表达降低与疾病进展相关。由于p63在β-catenin基因表达调控中的可能作用最近被提出,我们的研究结果表明Δ Np 63表达的下调可能是β-catenin表达下调的原因之一。采用多因素分析方法对浸润性膀胱癌根治术患者的预后进行分析。我们发现Δ Np 63表达降低是这些患者的显著和独立的预后因素,与pT分期以及pN分期沿着。少
英文摘要
Expression profile of p63 in the human urothelial cellsExpression profiles of p63 protein and mRNA in the primary culture of human urothelial cells and human urothelial carcinoma cell lines in vitro were examined using immunocytochemistry and RT-PCR Human urothelial basal cells strongly express ΔNp63 isoform. This ΔNp63 expression was preserved in well differentiated human urothelial carcinoma cell lines, while was impaired in poorly differentiated human urothelial carcinoma cell lines.Expression profile of p63 in normal human urothelial tract and urothelial carcinoma tissueExpression profiles of p63 protein and p63 mRNA isoforms were examined in the normal human urinary tract and human bladder cancer tissues using immunohistochemishy and RT-PCR assay, respectively. In the normal human urinary tract, p63 was expressed in the nucleus of urothelial cells in the basal to intermediate layer and only ΔN isoform was expressed. This expression pattern was preserved in well differentiated, non … More -invasive bladder cancers, while was diminished or disappeared in poorly differentiated, invasive bladder cancers. This in vivo finding was in good agreement with the aforementioned in vitro finding.In the invasive bladder cancer tissue, we found a significant association of decreased ΔNp63 expression with decreased β-catenin expression that has been known to associate with progression of the disease. Since possible role of p63 in the regulation of β-catenin gene expression has been recently suggested, our results indicated that down-regulation of ΔNp63 expression may be one of the causes of β-catenin down regulation.Prognostic significance of ΔNp63 expression in invasive bladder cancerΔNp63 expression was examined in surgically removed invasive bladder cancer tissue. Prognosis of patients with invasive bladder cancer treated with radical cystectomy was analyzed using multivariate analyses. We found that decreased ΔNp63 expression was significant and independent prognostic factors along with pT stage as well as pN stage in these patients. Less
期刊论文(20)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Koga F, Kawakami S, et al.: "Impaired ΔNp63 expression characterises aggressive phenotypes of urothelial neoplasms"British Journal of Cancer. 88. 740-747 (2003)
Koga F、Kawakami S 等人:“ΔNp63 表达受损表征尿路上皮肿瘤的侵袭性表型”英国癌症杂志 88. 740-747 (2003)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Peroxisome proliferators-activated receptor γ ligands suppress proliferation of human urothelial basal cells in vitro.
过氧化物酶体增殖物激活受体 γ 配体在体外抑制人尿路上皮基底细胞的增殖。
DOI:
--
发表时间:
2002
期刊:
Journal of Cellular Physiology 191
影响因子:
--
作者:
[Kawakami S, et al.]
通讯作者:
et al.
DOI:
--
发表时间:
2003-11
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
[F. Koga;S. Kawakami;Y. Fujii;K. Saito;Yukihiro Ohtsuka;A. Iwai;N. Ando;T. Takizawa;Y. Kageyama;K. Kihara]
通讯作者:
F. Koga;S. Kawakami;Y. Fujii;K. Saito;Yukihiro Ohtsuka;A. Iwai;N. Ando;T. Takizawa;Y. Kageyama;K. Kihara
Impaired ΔNp63 expression characterises aggressive phenotypes of urolthelial neoplasns
ΔNp63 表达受损是尿路上皮肿瘤侵袭性表型的特征
DOI:
--
发表时间:
2003
期刊:
British Journal of Cancer 88
影响因子:
--
作者:
[Koga F, Kawakami S, et al.]
通讯作者:
et al.
Kawakami S, et al.: "Peroxisome proliferator-activated receptor γ ligands suppress proliferation of human urothelial basal cells in vitro"Journal of Cellular Physiology. 191. 310-319 (2002)
Kawakami S 等人:“过氧化物酶体增殖物激活受体 γ 配体在体外抑制人尿路上皮基底细胞的增殖”《细胞生理学杂志》191. 310-319 (2002)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 8 条
国内基金
海外基金
登录
查看更多内容
Jag1/2启动子异常甲基化通过P63促进食管鳞癌免疫治疗耐药的机制研究
-
批准号:2024Y9328
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:林济红
-
依托单位:
MAGEA3与转录因子p63通过相分离互作调控细胞焦亡介导食管鳞癌化疗耐药的机制研究
-
批准号:82373035
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:饶栓
-
依托单位:
先锋转录因子p63通过重塑染色质结构调控肝内胆管癌相关基因KRT17的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:喻昕阳
-
依托单位:
p63介导的染色质重塑在氡暴露致肺癌发生中的作用及其分子机制研究
-
批准号:82103777
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:刘巧维
-
依托单位:
p63在食管上皮发育中的作用及调控机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:章永春
-
依托单位:
p63/YY1通过调控染色质结构激活SULF2介导肝癌的机制研究
-
批准号:32100447
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:喻昕阳
-
依托单位:
p63/circHERC4/miR-155轴调控子宫颈癌细胞铂耐药的分子机制
-
批准号:82172774
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2021
-
负责人:赵卫东
-
依托单位:
p63与KLF4协同调控ESCs表皮分化和应用于烧伤创面愈合的研究
-
批准号:82172198
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2021
-
负责人:韩春茂
-
依托单位:
p63介导的染色质重塑在氡暴露致肺癌发生中的作用及其分子机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2021
-
负责人:刘巧维
-
依托单位:
上皮转录因子p63与增强子调控鼻黏膜炎症上皮干细胞异常增殖和分化的机制研究
-
批准号:81974139
-
项目类别:面上项目
-
资助金额:59.0万元
-
批准年份:2019
-
负责人:李春炜
-
依托单位: